Pharma Journalist -

Intensity Therapeutics announced it has entered into a clinical trial collaboration agreement with Bristol Myers Squibb Company. The program will evaluate the safety and efficacy of…
Read More...

Sinovac Biotech Ltd. announced that the Company has obtained approval to conduct a human clinical trial on an inactivated SARS-CoV-2 (commonly referred to as COVID-19) vaccine…
Read More...

PharmaJet, the maker of innovative, needle-free injection technology, announced that its Tropis Needle-free injection system will be used to deliver a COVID-19 vaccine being developed…
Read More...

AstraZeneca will initiate a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib) in the treatment of the exaggerated immune response (cytokine storm)…
Read More...

Sanofi and GSK announce that they have signed a letter of intent to enter into a collaboration to develop an adjuvanted vaccine for COVID-19, using innovative technology from both…
Read More...

Immunotherapy companies led by Dr. Patrick Soon-Shiong are developing potential coronavirus therapeutics and vaccines to address the evolving stages of disease from moderate infection…
Read More...

Insilico Medicine announced that it has entered into a research collaboration with Boehringer Ingelheim to utilize Insilico's generative machine learning technology and proprietary…
Read More...

SMi Reports: The inaugural Pre-filled Syringes San Francisco will be held in San Francisco, USA this September SMi Group is delighted to announce the inaugural Pre-filled Syringes…
Read More...

Ascletis Pharma Inc. announces that it received IND approval from National Medical Products Administration (NMPA) for its human immunodeficiency virus (HIV) protease inhibitor ASC09F…
Read More...

Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced clearance by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for an orally available…
Read More...